Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study - Influence of Gemcitabine Treatment on Immunological and Serological Profile in Patients With Pancreatic Tubular Carcinoma

NCT00947102 is registered in ClinicalTrials.gov with Blood Transfusion Centre of Slovenia as lead sponsor.

NCT NCT00947102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00947102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study - Influence of Gemcitabine Treatment on Immunological and Serological Profile in Patients With Pancreatic Tubular Carcinoma
Lead sponsor
Blood Transfusion Centre of Slovenia
Phase
Observational
Overall status
Unknown status
Start date
February 28, 2009
Completion date
December 31, 2011
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic tubular adenocarcinoma